MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-05-2026
Neurocrine Biosciences DIO Ratio 2011-2026 | NBIX
Annual DIO Ratio Neurocrine Biosciences
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 443 | 514 | 337 | 516 | 747 | 818 | 850 | 811 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 850 | 337 | 629 |
Quarterly DIO Ratio Neurocrine Biosciences
| 2026-Q1 | 2025-Q4 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 441 | - | 468 | 578 | - | 504 | 395 | 459 | - | 246 | 258 | 368 | - | 277 | 276 | 590 | - | 584 | 860 | 914 | - | 946 | 1.06 K | 984 | - | 718 | 987 | 1.14 K | - | 639 | 1.16 K | 571 | - | 121 | 95.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.16 K | 95.7 | 602 |
DIO Ratio of other stocks in the Biotechnology industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
FSD Pharma
HUGE
|
174 | - | 5743.5 % | $ 69.7 M |  Canada |
 |
Happiness Biotech Group Limited
HAPP
|
1.91 K | - | 1.35 % | $ 17.8 M |  China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
512 | - | - | $ 40.3 B |  USA |
 |
AstraZeneca PLC
AZN
|
206 | - | - | $ 96.9 B |  Britain |
 |
Midatech Pharma plc
MTP
|
40.6 | - | -18.52 % | $ 27.3 M | Britain |
 |
Esperion Therapeutics
ESPR
|
2.46 K | $ 3.14 | 0.16 % | $ 653 M | USA |
 |
Eton Pharmaceuticals
ETON
|
150 | $ 35.13 | 1.97 % | $ 945 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
275 | - | - | - |  Russia |
 |
Berkeley Lights
BLI
|
246 | - | -7.31 % | $ 87 M | USA |
 |
Grifols, S.A.
GRFS
|
0.000171 | $ 8.14 | -0.67 % | $ 5.53 B |  Spain |
 |
Autolus Therapeutics plc
AUTL
|
70.7 | $ 1.66 | 2.47 % | $ 442 M | Britain |
 |
Heron Therapeutics
HRTX
|
644 | $ 0.87 | 2.78 % | $ 145 M | USA |
 |
Cyclacel Pharmaceuticals
CYCCP
|
185 | - | -4.36 % | $ 27 M | USA |
 |
Incyte Corporation
INCY
|
78.4 | $ 97.69 | 0.63 % | $ 19.1 B | USA |
 |
Anika Therapeutics
ANIK
|
159 | $ 15.09 | -0.33 % | $ 216 M | USA |
 |
Aeterna Zentaris
AEZS
|
55.6 | - | 5.93 % | $ 314 M | Canada |
 |
Ionis Pharmaceuticals
IONS
|
259 | $ 75.94 | 1.17 % | $ 12.2 B | USA |
 |
Coherus BioSciences
CHRS
|
97.5 | $ 1.6 | 5.61 % | $ 187 M | USA |
 |
Albireo Pharma
ALBO
|
26.1 | - | -0.23 % | $ 916 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
185 | $ 20.88 | 2.0 % | $ 2.66 B | USA |